CERO THERAPEUTICS HOLDINGS, INC. Operating Expenses
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Operating Expenses of $3.85 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-14
- CERO THERAPEUTICS HOLDINGS, INC. operating expenses for the quarter ending 2026-06-30 was $3.85M, a 18.57% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. operating expenses for the quarter ending 2026-03-31 was $4.85M, a 2.12% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. operating expenses for the quarter ending 2025-09-30 was $4.36M, a 0.90% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. operating expenses for the quarter ending 2025-06-30 was $4.72M, a 8.24% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. operating expenses for fiscal 2023 was $7.68M, a 164.16% increase from fiscal 2022.
- CERO THERAPEUTICS HOLDINGS, INC. operating expenses for fiscal 2022 was $2.91M.
| Period end | Operating Expenses 1 month | Operating Expenses 2 month | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 4 month | Operating Expenses 5 month | Operating Expenses 6 month | Operating Expenses 7 month | Operating Expenses 8 month | Operating Expenses 9 month | Operating Expenses 11 month | Operating Expenses 12 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.85M 10-Q · filed 2026-08-14 | $8.69M 10-Q · filed 2026-08-14 | ||||||||||
| 2026-03-31 | $4.85M 10-Q · filed 2026-05-15 | |||||||||||
| 2025-09-30 | $4.36M 10-Q · filed 2025-11-19 | $9.09M derived: sum of 2 quarters · filed 2026-08-14 | $14.04M 10-Q · filed 2025-11-19 | |||||||||
| 2025-06-30 | $4.72M 10-Q · filed 2026-08-14 | $9.67M 10-Q · filed 2026-08-14 | ||||||||||
| 2025-03-31 | $4.95M 10-Q · filed 2026-05-15 | |||||||||||
| 2024-12-31 | $15.30M 10-K · filed 2025-04-15 | |||||||||||
| 2024-09-30 | $4.40M 10-Q · filed 2025-11-19 | $9.55M derived: sum of 2 quarters · filed 2025-11-19 | $13.21M 10-Q · filed 2025-11-19 | |||||||||
| 2024-06-30 | $5.15M 10-Q · filed 2025-08-22 | $8.80M 10-Q · filed 2025-08-22 | ||||||||||
| 2024-03-31 | $3.65M 10-Q · filed 2025-05-15 | |||||||||||
| 2024-02-13 | $897.13K 10-Q · filed 2025-11-19 | |||||||||||
| 2023-12-31 | $1.12M derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-04-15 | $2.66M derived: sum of 2 quarters · filed 2025-04-15 | $5.07M derived: sum of 3 quarters · filed 2025-04-15 | $7.68M 10-K · filed 2025-04-15 | ||||||||
| 2023-09-30 | $1.54M 10-Q/A · filed 2024-11-20 | $3.95M derived: sum of 2 quarters · filed 2024-11-20 | $6.55M 10-Q/A · filed 2024-11-20 | $7.68M derived: sum of 4 quarters · filed 2024-11-20 | ||||||||
| 2023-06-30 | $2.41M 10-Q · filed 2024-08-14 | $4.85M 10-Q · filed 2024-08-14 | $6.14M derived: sum of 3 quarters · filed 2024-08-14 | $6.98M derived: sum of 4 quarters · filed 2024-08-14 | ||||||||
| 2023-03-31 | $2.44M 10-Q · filed 2024-05-17 | $590.27K 10-Q · filed 2023-05-12 | $3.73M derived: sum of 2 quarters · filed 2024-05-17 | $4.56M derived: sum of 3 quarters · filed 2024-05-17 | $4.94M derived: sum of 4 quarters · filed 2024-05-17 | |||||||
| 2022-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $2.12M derived: sum of 2 quarters · filed 2023-03-24 | $2.50M derived: sum of 3 quarters · filed 2023-03-24 | $2.91M 10-K · filed 2023-03-24 | ||||||||
| 2022-09-30 | $836.68K 10-Q · filed 2022-11-10 | $1.21M derived: sum of 2 quarters · filed 2022-11-10 | $1.62M 10-Q · filed 2022-11-10 | |||||||||
| 2022-06-30 | $376.58K 10-Q · filed 2022-08-11 | $781.36K 10-Q · filed 2022-08-11 | ||||||||||
| 2022-03-31 | $404.78K 10-Q · filed 2023-05-12 | |||||||||||
| 2021-12-31 | $332.03K 10-K · filed 2023-03-24 | |||||||||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 | $1.00K 10-Q · filed 2022-11-10 | ||||||||||
| 2021-06-30 | $1.00K 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |